Get the Stockscreener App
132.53
2.62%
-3.57
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $132.53, with a volume of 785.46K.
It is down -2.62% in the last 24 hours and up +6.60% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$136.10
Open:
$134.42
24h Volume:
785.46K
Relative Volume:
0.34
Market Cap:
$37.44B
Revenue:
$7.23B
Net Income/Loss:
$1.41B
P/E Ratio:
26.62
EPS:
4.979
Net Cash Flow:
$1.09B
1W Performance:
-1.30%
1M Performance:
+6.60%
6M Performance:
-5.09%
1Y Performance:
+13.90%
1-Day Range:
$131.91
$135.79
1-Week Range:
$131.91
$136.91
52-Week Range:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
132.57 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
533.28 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.94 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.93 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
270.94 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
A4404722 Bond Profile — Key Metrics - TradingView
World Syringes for AgilentMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
A4996671 Bond Profile — Key Metrics - TradingView
A5886204 Bond Profile — Key Metrics - TradingView
A5886359 Bond Profile — Key Metrics - TradingView
Agilent Technologies (NYSE:A) Nears A Technical Breakout - Kalkine Media
Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings - ChartMill
Agilent Technologies (A) Receives FDA Approval for New Diagnosti - GuruFocus
Agilent receives FDA approval for cancer diagnostic test By Investing.com - Investing.com South Africa
Agilent Technologies (A) Receives FDA Approval for PD-L1 IHC 28-8 pharmDx Kit - GuruFocus
Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma - marketscreener.com
Agilent receives FDA approval for cancer diagnostic test - Investing.com
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma - Business Wire
A6433334 Bond Profile — Key Metrics - TradingView
Agilent expands Altura HPLC column portfolio for biopharma By Investing.com - Investing.com Nigeria
Agilent Technologies stock reflects steady diagnostics demand - Ad Hoc News
Agilent (A): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating - marketscreener.com
Agilent Technologies, Inc. (A) Stock Analysis: Is There a Potential 18.56% Upside for Investors? - DirectorsTalk Interviews
Is Agilent Technologies (A) A Bargain Following Its New Lab Tools And AI Software? - Sahm
Why Is Agilent (NYSE:A) Launching New AI Chromatography Tools? - Kalkine Media
Tangible book value per share of Agilent Technologies, Inc. – LSX:929138 - TradingView
Agilent rises on Q2 beats; adjusts fiscal 2026 guidance - MSN
Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis - AOL.com
Agilent (NYSE:A) Deepens Its AI Biopharma Push - Kalkine Media
Agilent Technologies stock stays supported by life-science demand - ad-hoc-news.de
Does Agilent (A) Signal a Deeper Shift With New AI Biopharma Tools and Columns? - simplywall.st
Agilent Technologies Inc (A) Stock Up 3.5% and Still Undervalued -- GF Score: 93/100 - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Strengthens Biopharma Growth Prospects With AI Expansion - Yahoo Finance
AGILENT TECHNOLOGIES, INC. CMNRo Khanna Congressional Trade on Jun. 02, 2026 - Quiver Quantitative
Agilent expands Altura portfolio with inert size exclusion and PLRP-S columns for biotherapeutic analysis - BioSpectrum Asia
Agilent Technologies explores long-term growth drivers as a life sciences leader - ad-hoc-news.de
Jefferies resumes Agilent stock coverage with Hold rating By Investing.com - Investing.com South Africa
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis - Business Wire
Jefferies resumes Agilent stock coverage with Hold rating - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies earnings and business outlook. Investors focus on diagnostics and life sciences - ad-hoc-news.de
Agilent Expands HPLC Column Portfolio to Enhance Biotherapeutic Analysis - Contract Pharma
Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis - marketscreener.com
Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize? - Yahoo Finance
Agilent Slumps on Expansion Plans - TradingView
Agilent expands Altura HPLC column portfolio for biopharma - Investing.com
Agilent adds inert columns for tougher biopharma tests - Stock Titan
Agilent adds SEC and PLRP-S columns to Altura portfolio - StreetInsider
Agilent Technologies focuses on analytical solutions as investors watch long-term growth - ad-hoc-news.de
Agilent 1260 Infinity II LC from Agilent Technologiesworkhorse HPLC for busy US labs - ad-hoc-news.de
Agilent 6560 Ion Mobility LC/Q-TOF from Agilentniche lab workhorse gains quiet momentum - AD HOC NEWS
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):